Publikationen, an denen er mitarbeitet José Felix Martí Massó (87)

2020

  1. The Discovery of the Dardarin Gene 15 Years Later: A Globalized Local History

    Movement Disorders

2017

  1. Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease

    European Journal of Neurology, Vol. 24, Núm. 2, pp. 427-e6

  2. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study

    Movement Disorders, Vol. 32, Núm. 7, pp. 1066-1073

  3. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics

    PLoS ONE, Vol. 12, Núm. 6

  4. Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease

    Neurology: Genetics, Vol. 3, Núm. 5

  5. ¿Son la forma precoz y la de presentación tardía la misma enfermedad de Parkinson?

    Revista española de trastornos del movimiento, Vol. 9, Núm. 1, pp. 6-11

2016

  1. Congenital Spinal Malformation and Stroke: Aneurysmal Dilatations and Bilateral Rotational Vertebral Artery Occlusion

    Journal of Stroke and Cerebrovascular Diseases, Vol. 25, Núm. 3, pp. e23-e24

  2. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 3, pp. 335-343

  3. Genetic Mutation Analysis of Parkinson’s Disease Patients Using Multigene Next-Generation Sequencing Panels

    Molecular Diagnosis and Therapy, Vol. 20, Núm. 5, pp. 481-491

  4. Inflammatory profile in LRRK2-associated prodromal and clinical PD

    Journal of Neuroinflammation, Vol. 13, Núm. 1

2015

  1. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

    Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722

  2. Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease

    JAMA Neurology, Vol. 72, Núm. 1, pp. 100-105

  3. GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment

    Journal of Human Genetics, Vol. 60, Núm. 10, pp. 637-640

  4. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease a pooled analysis

    JAMA Neurology, Vol. 72, Núm. 1, pp. 58-65

  5. Leucoencefalopatía multifocal progresiva: La imagen como prueba clave

    Revista de Neurologia

  6. SORT1 Mutation Resulting in Sortilin Deficiency and p75(NTR) Upregulation in a Family With Essential Tremor

    ASN neuro, Vol. 7, Núm. 4

2014

  1. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2

    Parkinsonism and Related Disorders, Vol. 20, Núm. 10, pp. 1097-1100

  2. Michael J. Fox Foundation LRRK2 Consortium: Geographical differences in returning genetic research data to study participants

    Genetics in Medicine

  3. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2

    Movement Disorders, Vol. 29, Núm. 6, pp. 750-755

2013

  1. Cerebellitis acute Epstein-Barr virus in two young women

    Revista de Neurologia